← Open Payments lookup

CHRISTINA BOORD: Open Payments

NPI 1336815091 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,182 in 48 payments from 11 companies in 2025. Trend: 2023 $455 · 2024 $771 · 2025 $2,182

Long term medical supply or device loan: $1,147Food & beverage: $935Education: $99
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$1,205
Daiichi Sankyo Inc.11$297
Gilead Sciences, Inc.9$229
SEAGEN INC.1$99
TerSera Therapeutics LLC3$84
Merck Sharp & Dohme LLC3$83
PFIZER INC.2$52
Genentech USA, Inc.2$48
Takeda Pharmaceuticals U.S.A., Inc.1$36
Lilly USA, LLC1$31

Products named: KISQALI, Enhertu, Trodelvy, Zoladex, KEYTRUDA, FRUZAQLA, VERZENIO, Itovebi.

Industry payments across MD — which companies pay providers there.